Pharmacy Medical News about nuvigil; armodafinil; wakefulness promoter

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Agent battles excessive sleepiness
The Clinical Advisor, 09/01/09

Nuvigil. Indication: To improve wakefulness in patients with excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome (OSAHS), narcolepsy, and shift–work sleep disorder (SWSD). Adjunct to standard treatment for underlying airway obstruction in OSAHS. Armodafinil is the R–enantiomer of modafinil (Provigil). Of the two enantiomers that comprise modafinil, the R–form is longer lasting. Both of these drugs have wakefulness– promoting effects similar to those of sympathomimetics such as amphetamines and methylphenidate.